Evidence map›Paper›PMID 10858439›Full record

ArticleThe Journal of biological chemistry2000

Cytokine signaling through Stat3 activates integrins, promotes adhesion, and induces growth arrest in the myeloid cell line 32D.

D K Wooten, X Xie, D Bartos, R A Busche, G D Longmore, S S Watowich

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. β2 Integrins-Multi-Functional Leukocyte Receptors in Health and Disease.International journal of molecular sciences · 2020
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Erythropoietin receptors that signal through Stat5 or Stat3 support fetal liver and adult erythropoiesis: lack of specificity of stat signals during red blood cell development.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2000
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

D K WootenDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
X Xie
D Bartos
R A Busche
G D Longmore
S S Watowich
The University of Texas MD Anderson Cancer Center · USWashington University in St. Louis · US

Funding

MOLECULAR MECHANISMS CYTOKINE RECEPTOR SIGNALINGR01CA077447 · NCI · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI WATOWICH, STEPHANIE S · 1998 to 2000
$250k
REGULATION OF RED CELL DEVELOPMENT AND LEUKEMOGENESISR01CA075315 · NCI · WASHINGTON UNIVERSITY · PI LONGMORE, GREGORY · 1997 to 2000
$23k
NCI NIH HHS CA 75315NCI NIH HHS CA 77447NCI NIH HHS R01 CA077447
6 · The paper itself

Abstract

Hematopoietic cell development and function is dependent on cytokines and on intercellular interactions with the microenvironment. Although the intracellular signaling pathways stimulated by cytokine receptors are well described, little is known about the mechanisms through which these pathways modulate hematopoietic cell adhesion events in the microenvironment. Here we show that cytokine-activated Stat3 stimulates the expression and function of cell surface adhesion molecules in the myeloid progenitor cell line 32D. We generated an erythropoietin receptor (EpoR) isoform (ER343/401-S3) that activates Stat3 rather than Stat5 by substituting the Stat3 binding/activation sequence motif from gp130 for the sequences surrounding tyrosines 343 and 401 in the receptor cytoplasmic region. Activation of Stat3 leads to homotypic cell aggregation, increased expression of intercellular adhesion molecule 1 (ICAM-1), CD18, and CD11b, and activation of signaling through CD18-containing integrins. Unlike the wild type EpoR, ER343/401-S3 is unable to support long term Epo-dependent proliferation in 32D cells. Instead, Epo-treated ER343/401-S3 cells undergo G(1) arrest and express elevated levels of the cyclin-dependent kinase inhibitor p27(Kip1). Sustained activation of Stat3 in these cells is required for their altered morphology and growth properties since constitutive SOCS3 expression abrogates homotypic cell aggregation, signaling through CD18-containing integrins, G(1) arrest, and accumulation of p27(Kip1). Collectively, our results demonstrate that cytokine-activated Stat3 stimulates the expression and function of cell surface adhesion molecules, indicating that a role for Stat3 is to regulate intercellular contacts in myeloid cells.

Indexed as

Cell Cycle ProteinsTumor Suppressor ProteinsAnimalsCD18 AntigensCell AdhesionCyclin-Dependent Kinase Inhibitor p27CytokinesDNA-Binding ProteinsEnzyme ActivationG1 PhaseGranulocyte Colony-Stimulating FactorHematopoietic Stem CellsIntegrinsIntercellular Adhesion Molecule-1Macrophage-1 AntigenMiceCD18 AntigensCdkn1b protein, mouseCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p27CytokinesDNA-Binding ProteinsGranulocyte Colony-Stimulating FactorIntegrinsIntercellular Adhesion Molecule-1Macrophage-1 AntigenMicrotubule-Associated ProteinsReceptors, ErythropoietinStat3 protein, mouseSTAT3 Transcription FactorTrans-ActivatorsTumor Suppressor Proteins

Identifiers

PMID10858439
PMCPMC2396147
OpenAlexW2004243702

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.